Physician profile
Steven M Camp
NPI 1235267519
$159,091.12
in general payments reported to CMS, 2019-2025
16 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,275 · 2020: $4,416 · 2021: $39K · 2022: $57K · 2023: $30K · 2024: $11K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Consulting Fee: $12K · Food and Beverage: $8,440 · Travel and Lodging: $1,233 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,161.40 |
| Consulting Fee | $12,100.00 |
| Food and Beverage | $8,439.86 |
| Travel and Lodging | $1,233.29 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $101,955.32 | 2019-2023 | |
| Abbvie INC. | $46,481.50 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Motiva USA, LLC | $4,142.01 | 2025 | |
| Davol INC. | $3,715.13 | 2022-2025 | Phasix Mesh, Galaflex |
| Tepha INC | $1,117.59 | 2019-2020 | |
| Sientra, INC. | $596.53 | 2019-2021 | |
| Galderma Laboratories, L.P. | $315.52 | 2020-2025 | Dysport |
| Revance Therapeutics, INC. | $218.79 | 2025 | Daxxify |
| Musculoskeletal Transplant Foundation INC. | $169.48 | 2019-2025 | |
| Tela Bio, INC. | $148.88 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $93.15 | 2025 | Pico 7 |
| Merz North America, INC. | $47.09 | 2021 | |
| Apyx Medical Corporation | $25.57 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.38 | 2025 | |
| Integra Lifesciences Corporation | $20.02 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $19.16 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Camp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.